Patients with newly diagnosed multiple myeloma (NDMM) treated at a specialized clinic have improved outcomes, with median overall survival (OS) of 152 months, according to a research letter published in the November issue of Haematologica.
Continue Reading
News Source: medicalxpress.com
Leave a Reply